Tivic Health flagged by Nasdaq for sub-$1 share price

Tivic Health Systems, Inc. reported that Nasdaq has notified the company it is not in compliance with the Nasdaq Capital Market’s minimum bid price rule because its common stock closed below $1.00 per share for at least 30 consecutive business days.

Rhea-AI Filing Summary

Tivic Health Systems, Inc. reported that Nasdaq has notified the company it is not in compliance with the Nasdaq Capital Market’s minimum bid price rule because its common stock closed below $1.00 per share for at least 30 consecutive business days. The stock remains listed for now, and Tivic has 180 days from March 19, 2026, through September 15, 2026, to regain compliance by having its closing bid at or above $1.00 for at least 10 consecutive business days. If it fails to do so, Nasdaq may grant an additional 180‑day grace period if other listing standards are met and Tivic indicates an intent to cure the deficiency; otherwise the shares could be subject to delisting, with a right of appeal.

Positive

• None.

Negative

• Nasdaq noncompliance and delisting risk: Tivic Health Systems’ stock traded below $1.00 for at least 30 consecutive business days, triggering a Nasdaq minimum bid price deficiency notice and creating a defined risk of eventual delisting if compliance is not restored.

Insights

Equity listing & capital markets analyst

Nasdaq minimum-bid noncompliance introduces delisting risk if not cured.

Tivic Health Systems has fallen below Nasdaq’s $1.00 minimum bid price for 30 consecutive business days, triggering a formal noncompliance notice. The shares remain on the Nasdaq Capital Market, but the company now operates under a defined cure timetable.

Under Nasdaq rules, Tivic has 180 days from March 19, 2026 to restore a closing bid at or above $1.00 for at least 10 straight trading days. If it satisfies all other initial listing standards, it may receive a second 180‑day period.

If compliance is not regained within the allowed periods, Nasdaq can move to delist the stock, though Tivic would have the right to appeal to a hearings panel. Actual outcomes will depend on future share-price performance and any actions the company undertakes within these stated windows.

8-K Event Classification

Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

1 item

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities

The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What Nasdaq issue did Tivic Health Systems (TIVC) disclose?

Tivic Health Systems disclosed that Nasdaq notified the company it is not in compliance with the minimum bid price rule, because its common stock closed below $1.00 per share for at least 30 consecutive business days on the Nasdaq Capital Market.

Does the Nasdaq notice immediately affect Tivic Health Systems’ (TIVC) listing?

The notice has no immediate effect on Tivic Health Systems’ listing. Its common stock continues to trade on the Nasdaq Capital Market while the company works within the allowed compliance period to restore its share price above the $1.00 minimum bid requirement.

How long does Tivic Health Systems (TIVC) have to regain Nasdaq bid price compliance?

Tivic Health Systems has 180 calendar days from March 19, 2026, through September 15, 2026, to regain compliance. It must achieve a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days within this period.

Can Tivic Health Systems (TIVC) receive more time beyond September 15, 2026?

Nasdaq may grant Tivic Health Systems a second 180‑day grace period if it meets all other initial listing standards, including market value of publicly held shares, and formally notifies Nasdaq of its intent to cure the minimum bid price deficiency.

What happens if Tivic Health Systems (TIVC) cannot regain Nasdaq compliance?

If Tivic Health Systems fails to regain compliance within the allowed 180‑day period and any granted extension, Nasdaq may move to delist its common stock from the Nasdaq Capital Market. The company would then be entitled to appeal that determination to a Nasdaq hearings panel.

What steps did Tivic Health Systems (TIVC) say it will take regarding the Nasdaq deficiency?

Tivic Health Systems stated it intends to continue actively monitoring the closing bid price of its common stock through September 15, 2026, and will consider available options to resolve the minimum bid price deficiency and regain compliance with Nasdaq’s continued listing requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/20/2026 - 05:15 PM Learn about SEC filing dates

false 0001787740 0001787740 2026-03-19 2026-03-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 19, 2026

Tivic Health Systems, Inc.

(Exact name of Registrant as Specified in Its Charter)

Delaware		001-41052		81-4016391
(State or Other Jurisdiction		(Commission File Number)		(IRS Employer
of Incorporation)				Identification No.)
1305 E. Houston Street, Building 1, Suite 311
San Antonio, Texas				78205
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s Telephone Number, Including Area Code: 888 276-6888

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		TIVC		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On March 19, 2026, Tivic Health Systems, Inc. (the “Company”) received a notification letter from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s common stock was below $1.00 per share for at least 30 consecutive business days, the Company is not currently in compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).

The notification has no immediate effect on the listing of the Company’s common stock on The Nasdaq Capital Market, and, therefore, the Company’s listing remains fully effective.

In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a period of 180 calendar days from March 19, 2026 or until September 15, 2026, to regain compliance with the Minimum Bid Price Requirement. If at any time before September 15, 2026, the closing bid price of the Company’s common stock closes at or above $1.00 per share for a minimum of 10 consecutive business days, Nasdaq will provide written notification that the Company has achieved compliance with the Minimum Bid Price Requirement, and the matter would be resolved. If the Company does not regain compliance during the compliance period ending on September 15, 2026, then Nasdaq may grant the Company a second 180 calendar day grace period to regain compliance, provided the Company (i) meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and (ii) the Company notifies Nasdaq of its intent to cure the deficiency.

The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and September 15, 2026, and will consider available options to resolve the deficiency and regain compliance with the Minimum Bid Price Requirement. If the Company does not regain compliance within the allotted compliance period, including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that the Company’s common stock will be subject to delisting. The Company would then be entitled to appeal that determination to a Nasdaq hearings panel. There can be no assurance that the Company will regain compliance with the Minimum Bid Price Requirement during the 180-day compliance period, secure a second period of 180 days to regain compliance, or maintain compliance with the other Nasdaq listing requirements.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			TIVIC HEALTH SYSTEMS, INC.
Date:	March 20, 2026	By:	/s/ Lisa Wolf
			Name: Lisa Wolf Title: Chief Financial Officer

3

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL SCHEMA FILE 2.9 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.8 KB